Surgical Treatment of Early-Stage Breast Cancer

Chapter
First Online:

Abstract

Early-stage breast cancer is an issue of growing clinical importance due to ever-increasing rates of breast lesion detection. Wide population-based screening programs and improved visualization techniques are powerful tools for the early and more precise evaluation of breast tumors. Optimally timed and safe surgical approaches are needed to provide local control with satisfactorily high survival.

 In this chapter, we attempt to define the entity of early breast cancer and the mainstream surgical approach in light of modern achievements in the surgical treatment of breast cancer.

Keywords

Breast-conserving surgery Wound infection Mastectomy Surgical complications Local recurrence Lymphedema Surgical border 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin. 2006;56(1):37–47.CrossRefPubMedGoogle Scholar
  2. 2.
    Hambly NM, Mc Nicholas MM, Phelan N, Hargaden GC, O’Doherty A, Flanagan FL. Comparison of digital mammography and screen-film mammography in breast cancer screening: a review in the Irish breast screening program. AJR Am J Roentgenol. 2009;193(4):1010–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Hakim CM, Chough DM, Ganott MA, Sumkin JH, Zuley ML, Gur D. Digital breast tomosynthesis in the diagnostic environment: a subjective side-by-side review. AJR Am J Roentgenol. 2010;195(2):W172–6.CrossRefPubMedGoogle Scholar
  4. 4.
    Solin LJ. Counterview: pre-operative breast MRI (magnetic resonance imaging) is not recommended for all patients with newly diagnosed breast cancer. Breast. 2010;19(1):7–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Kheirelseid EA, Jumustafa H, Miller N, Curran C, Sweeney K, Malone C, et al. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics. Breast Cancer Res Treat. 2011;126(1):131–40.CrossRefPubMedGoogle Scholar
  6. 6.
    Halsted WS. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Ann Surg. 1894;20:497–555.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Meyer W. An improved method of the radical operation for carcinoma of the breast. Med Rec NY. 1894;46:746.Google Scholar
  8. 8.
    Halsted WS. The results of radical operations for the cure of cancer of the breast. Tr Am S A. 1907;25:61.Google Scholar
  9. 9.
    Özmen V. Meme cerrahisinin tarihçesi ve cerrahi tekniklerin gelişimi. In: Topuz, editor. Meme Kanseri. İstanbul Üniversitesi Onkoloji Enstitüsü yayınları 3. 1997. p. 218–228.Google Scholar
  10. 10.
    Özmen V. Meme koruyucu cerrahide prospektif randomize klinik çalışmalar. In: Topuz E, Aydıner A, Dinçer M, editors. Meme Kanseri. Nobel Tıp Kitabevleri. 2003. p. 297–300.Google Scholar
  11. 11.
    Patey DH, Dyson WH. The prognosis of carcinoma of the breast in relation to the type of mastectomy performed. Br J Cancer. 1948;2:7–13.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Auchincloss H. Modified radical mastectomy: why not? Am J Surg. 1970;119(5):506–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Cunningham M, Bunn F, Handscomb K. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database Syst Rev. 2006;2, CD005360.PubMedGoogle Scholar
  14. 14.
    Throckmorton AD, Boughey JC, Boostrom SY, Holifield AC, Stobbs MM, Hoskin T, et al. Postoperative prophylactic antibiotics and surgical site infection rates in breast surgery patients. Ann Surg Oncol. 2009;16(9):2464–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999;340:77–84.CrossRefPubMedGoogle Scholar
  16. 16.
    Karanlık H, Ozmen V, Asoglu O, İgci A, Keçer M, Tuzlali S, et al. Long term results of breast cancer surgery. J Breast Health. 2006;2:89–95.Google Scholar
  17. 17.
    Rebbeck TR, Freibel T, Lynch HT, Neuhausen SL, van ’t Veer L, Garber JE, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol. 2004;22:1055–62.CrossRefPubMedGoogle Scholar
  18. 18.
    Kuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S, et al. Effect of mechanical closure of dead space on seroma formation after breast surgery. Breast Cancer. 2006;13:260–5.CrossRefPubMedGoogle Scholar
  19. 19.
    Tadych K, Donegan WL. Postmastectomy seromas and wound drainage. Surg Gynecol Obstet. 1987;165(6):483–7.PubMedGoogle Scholar
  20. 20.
    Shamley DR, Barker K, Simonite V, Beardshaw A. Delayed versus immediate exercises following surgery for breast cancer: a systematic review. Breast Cancer Res Treat. 2005;90(3):263–71.CrossRefPubMedGoogle Scholar
  21. 21.
    Vitug AF, Newman LA. Complications in breast surgery. Surg Clin North Am. 2007;87(2):431–51.CrossRefPubMedGoogle Scholar
  22. 22.
    Carless PA, Henry DA. Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery. Br J Surg. 2006;93(7):810–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Rowell NP. Are mastectomy resection margins of clinical relevance? A systematic review. Breast. 2010;19(1):14–22.CrossRefPubMedGoogle Scholar
  24. 24.
    Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.CrossRefPubMedGoogle Scholar
  25. 25.
    Gruber G, Cole BF, Castiglione-Gertsch M, Holmberg SB, Lindtner J, Golouh R et al. International Breast Cancer Study Group. Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. Ann Oncol. 2008;19(8):1393–401.Google Scholar
  26. 26.
    Elkhuizen PH, van Slooten HJ, Clahsen PC, Hermans J, van de Velde CJ, van den Broek LC, et al. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. J Clin Oncol. 2000;18(5):1075–83.PubMedGoogle Scholar
  27. 27.
    http://ec.europa.eu/health/ph_projects/2002/cancer/fp.pdf. European guidelines for quality assurance of breast cancer screening, diagnosis, and treatment 4th edition, 2006.
  28. 28.
    Ozmen V. Meme hastalıklarının cerrahi tedavisinin kalitesi nasıl yükseltilebilir? Meme Sağlığı Dergisi. 2009;3:119–21.Google Scholar
  29. 29.
    Fisher B. The present status of tumor immunology. Adv Surg. 1971;5:189–254. Review.PubMedGoogle Scholar
  30. 30.
    Fisher B, Wolmark N, Fisher ER, Deutsch M. Lumpectomy and axillary dissection for breast cancer: surgical, pathological, and radiation considerations. World J Surg. 1985;9:692–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Atkins HJ, Hayward JL, Klugman DJ, Wayte AB. Treatment of early breast cancer. A report after ten years of clinical trial. Br MJ. 1972;2:423–9.Google Scholar
  32. 32.
    Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–41.CrossRefPubMedGoogle Scholar
  33. 33.
    Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–32.CrossRefPubMedGoogle Scholar
  34. 34.
    Jacobson JA, Danforth DN, Cowan KH, d’Angelo T, Steinberg SM, Pierce L, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995;332(14):907–11.CrossRefPubMedGoogle Scholar
  35. 35.
    van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr. 1992;11:15–8.PubMedGoogle Scholar
  36. 36.
    Blichert-Toft M, Rose C, Andersen JA, Overgaard M, Axelsson CK, Andersen KW, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr. 1992;11:19–25.PubMedGoogle Scholar
  37. 37.
    Arriagada R, Lê MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol. 1996;14(5):1558–64.PubMedGoogle Scholar
  38. 38.
    Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Eng J Med. 1995;333:1444.CrossRefGoogle Scholar
  39. 39.
    Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881–10882 trial. J Clin Oncol. 2007;25(22):3259–65.CrossRefPubMedGoogle Scholar
  40. 40.
    Punglia RS, Morrow M, Winer EP, Harris JR. Local therapy and survival in breast cancer. N Engl J Med. 2007;356(23):2399–405.CrossRefPubMedGoogle Scholar
  41. 41.
    Olsen MA, Chu-Ongsakul S, Brandt KE, Dietz JR, Mayfield J, Fraser VJ. Hospital-associated costs due to surgical site infection after breast surgery. Arch Surg. 2008;143(1):53–60; discussion 61.CrossRefPubMedGoogle Scholar
  42. 42.
    Indelicato D, Grobmyer SR, Newlin H, Morris CG, Haigh LS, Copeland 3rd EM, et al. Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing breast conserving therapy for early-stage breast cancer. Surgery. 2007;141(5):645–53.CrossRefPubMedGoogle Scholar
  43. 43.
    Morrow M, Hamilton AS, Katz SJ. Why do women get mastectomy? Results from a population based study. J Clin Oncol. 2007;25(18S):28S. Abstract 605.Google Scholar
  44. 44.
    Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg. 2005;241:629–39.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Morrow M. Margins in breast-conserving therapy: have we lost sight of the big picture? Expert Rev Anticancer Ther. 2008;8:1193–6.CrossRefPubMedGoogle Scholar
  46. 46.
    Fine RE, Schwalke MA, Pellicane JV, Attai DJ. A novel ultrasound-guided electrosurgical loop device for intra-operative excision of breast lesions; an improvement in surgical technique. Am J Surg. 2009;198(2):283–6.CrossRefPubMedGoogle Scholar
  47. 47.
    Veronesi U, Luini A, Galimberti V, Zurrida S. Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials. World J Surg. 1994;18(1):70–5.CrossRefPubMedGoogle Scholar
  48. 48.
    Pleijhuis RG, Graafland M, de Vries J, Bart J, de Jong JS, van Dam GM. Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Ann Surg Oncol. 2009;16(10):2717–30.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Blair SL, Thompson K, Rococco J, Malcarne V, Beitsch PD, Ollila DW. Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons? J Am Coll Surg. 2009;209(5):608–13.CrossRefPubMedGoogle Scholar
  50. 50.
    Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. American Society of Clinical Oncology. J Clin Oncol. 2013;31(7):961.CrossRefPubMedGoogle Scholar
  51. 51.
    Meric F, Bucholz TA, Mirza NQ, Vlastos G, Ames FC, Ross MI, et al. Long-term complications associated with breast conserving surgery and radiotherapy. Ann Surg Oncol. 2002;9:543–9.CrossRefPubMedGoogle Scholar
  52. 52.
    de Glas NA, Kiderlen M, Bastiaannet E, de Craen AJ, van de Water W, van de Velde CJ, et al. Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis. Breast Cancer Res Treat. 2013;138(2):561–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of SurgeryIstanbul University Istanbul Faculty of MedicineIstanbulTurkey
  2. 2.Breast Center, Istanbul Florence Nightingale HospitalIstanbulTurkey

Personalised recommendations